Announcements

We are delighted to share some highly cited Special Issues in 2024 from the “Cancer Immunology and Immunotherapy” Section of Cancers (ISSN: 2072-6694).

The list of highly cited Special Issues can be viewed below:

“Inflammation, Immunity, and Cancer Progression”
Guest Editors: Dr. Deepak Parashar, Dr. Vivek K. Kashyap and Dr. Subhash Tripathi
Submission deadline: 31 May 2024

“PD-1/PD-L1 Immune Checkpoint Therapy: From Predictive Biomarkers to Noninvasive Imaging”
Guest Editors: Prof. Dr. Patrizia Ferroni, Prof. Dr. Fiorella Guadagni and Prof. Dr. Mario Roselli
Submission deadline: 25 April 2024

“Role of Immune Checkpoint Inhibitors or Targeted Therapy in the Treatment of Patients with Melanoma Volume II”
Guest Editors: Dr. Henrik Schmidt and Dr. Eva Ellebæk
Submission deadline: 20 September 2024

“Near-Infrared Photoimmunotherapy for Cancer Treatment”
Guest Editor: Dr. Hisataka Kobayashi
Submission deadline: 10 April 2024

“Macrophage-Directed Cancer Immunotherapy”
Guest Editor: Dr. Zahra Payandeh
Submission deadline: 31 December 2024

“State-of-the-Art Cancer Immunology and Immunotherapy in the USA”
Guest Editors: Prof. Dr. Razelle Kurzrock, Dr. Anwaar Saeed, Dr. Linlin Guo and Dr. Ludimila Cavalcante
Submission deadline: 20 June 2024

We invite you to read and submit relevant papers to the journal Cancers using the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are pleased to announce that six new scholars have been appointed as Editorial Board Members (EBMs) of Cancers (ISSN: 2072-6694), joining in July 2025. We wish our new members success in both their research and their efforts to develop the journal.

Further details about the Editorial Board of Cancers can be found by clicking the following link: https://www.mdpi.com/journal/cancers/editors.

Cancers is recruiting scholars from around the world to join our Editorial Board. To apply for membership, recommend potential candidates, or request further information, please contact the Cancers Editorial Office and provide the following files:

• A full academic CV;
• A short cover letter that details your interest in the position.

We are delighted to share some highly cited Special Issues in 2024 in the “Cancer Survivorship and Quality of Life” Section in Cancers (ISSN: 2072-6694).

The list of highly cited Special Issues can be viewed below:

“Supportive Care for Patients with Cancer” Guest Editor: Prof. Dr. Andrew Davies Viewed by: 49330+	“Latest Advancements in Health-Related Quality of Life Research in Cancer Survivorship” Guest Editors: Prof. Dr. Thomas Licht and Prof. Dr. Richard Crevenna Viewed by: 33540+
“Advances in Supportive and Palliative Care in Cancer” Guest Editor: Prof. Dr. Sriram Yennurajalingam Viewed by: 25120+	“Medical Complications and Supportive Care in Patients with Cancer” Guest Editor: Dr. Javier Marco-Hernández Viewed by: 18810+
“Advanced Strategies in the Care of Hepatocellular Carcinoma Patients” Guest Editors: Prof. Dr. Matteo Donadon and Prof. Dr. Guido Torzilli Viewed by: 20590+	“Cancer Pain: From Basic Research to Drug Discovery and Clinical Studies” Guest Editors: Dr. Arpad Szallasi, Prof. Dr. Gabriela Trevisan and Dr. Andreea Dumele Viewed by: 17040+

We invite you to read and submit relevant papers to the journal Cancers using the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are delighted to share some highly cited Special Issues in 2024 in the “Transplant Oncology” Section in Cancers (ISSN: 2072-6694).

The list of highly cited Special Issues can be viewed below.

“Advances and Future Developments in Liver Transplantation for Cancers”
Guest Editors: Dr. Nicolas Golse, Dr. Giammauro Berardi, Dr. François Cauchy and Dr. Takashi Kokudo
Viewed by: 12025+

“Liver Transplantation for Liver Malignancies: Pushing the Limits Further”
Guest Editor: Prof. Dr. Long-Bin Jeng
Viewed by: 4145+

“Lung Transplantation and Lung Cancer: Clinical Scenarios, Outcomes and Future Perspectives”
Guest Editors: Dr. Andrea Dell'Amore, Dr. Eleonora Faccioli and Dr. Alessio Campisi
Viewed by: 10280+

“Liver Transplantation for Hepatocellular Carcinoma”
Guest Editors: Prof. Dr. Daniel Cherqui and Prof. Dr. Olivier Rosmorduc
Viewed by: 6755+

“Liver Transplantation for Cancer: The Future of Transplant Oncology”
Guest Editor: Prof. Dr. Tomoharu Yoshizumi
Viewed by: 4050+

We invite you to read and submit relevant papers to the journal Cancers using the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

The ESMO Congress is a significant global oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2025 aims to converge groundbreaking discoveries, innovative treatments and collaborative approaches to shape the future of cancer care. This event provides the opportunity to learn from internationally renowned experts, engage in thought-provoking discussions and connect with fellow oncology professionals who are advancing diagnosis, treatment and survivorship in this field.

The following MDPI journals will be represented at this conference:

• Cancers;
• Current Oncology;
• Life;
• JCM;
• Hematology Reports;
• CIMB;
• Cells;
• Oral;
• Uro;
• Pharmaceuticals;
• Gastroenterology Insights;
• Diagnostics;
• Targets;
• JPM;
• Onco;
• Radiation;
• Diseases;
• Hemato;
• Livers.

If you are planning to attend the above conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth #P2007 and answering any questions that you may have.

For more information about this conference, please visit the following website: https://www.esmo.org/meeting-calendar/esmo-congress-2025.

We are delighted to share some highly cited Special Issues in 2024 from the “Methods and Technologies Development” Section of Cancers (ISSN: 2072-6694).

The list of highly cited Special Issues can be viewed below:

“The Use of Real World (RW) Data in Oncology” Guest Editor: Dr. Christopher T. Wilke Submission deadline: 31 August 2024	“Computational Studies of Mutagenic Processes in Cancer” Guest Editors: Dr. Teresa M. Przytycka and Dr. Damian Wójtowicz Submission deadline: 15 December 2024
“Artificial Intelligence in Cancer Research: Knowledge Representation and Data Perspectives” Guest Editors: Dr. Catia Pesquita and Dr. Andreas Schlicker Submission deadline: 15 August 2024	“Advances in Cancer Data and Statistics” Guest Editor: Prof. Dr. Vesna Zadnik   Submission deadline: 30 December 2024
“Novel Insights in Acute Lymphoblastic and Myeloblastic Leukemia” Guest Editor: Dr. María Hernández Valladares Submission deadline: 29 February 2024	“Computational Pathology for Breast Cancer and Gynecologic Cancer” Guest Editor: Prof. Dr. Ching-Wei Wang Submission deadline: 31 March 2024

We invite you to read and submit relevant papers to the journal Cancers using the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

Cancers (ISSN: 2072-6694) is an open access journal, granting its readers free and unlimited access to all full-text articles. We welcome you to read the following highly cited Special Issues published in 2024 (now closed for submissions) in the “Molecular Cancer Biology” Section: 

1. “Autologous Stem Cell Transplantation or New Cellular Therapies for Neoplasias”
Guest Editor: Prof. Dr. Gabriela Maria Baerlocher
Views: 27880+

2. “Liver Cancers Molecular Biomarkers Predicting Outcome”
Guest Editor: Dr. Nima Kokabi
Views: 37870+

3. “2nd Edition: Estrogen Receptor-Positive (ER+) Breast Cancers”
Guest Editors: Prof. Dr. Christos Papadimitriou, Dr. Angelos Koutras and Dr. Eleni Timotheadou
Views: 27660+

4. “Gastric Cancers: Molecular Mechanisms, Novel Targets and Immunotherapies: From Bench to Clinical Therapeutics”
Guest Editors: Prof. Dr. Jaffer A. Ajani and Prof. Dr. Shumei Song
Views: 20590+

5. “Drug Repurposing and Reformulation for Cancer Treatment”
Guest Editors: Prof. Dr. Dhimant Desai, Prof. Dr. Arati Sharma and Dr. Abhijit Date
Views: 34640+

6. “Combined Hepatocellular-Cholangiocarcinoma: An Update on Epidemiology, Classification, Diagnosis and Management”
Guest Editor: Prof. Dr. Marcus Bahra
Views: 24470+

We are pleased to invite you to read the highly cited Special Issues in 2024 related to the “Cancer Pathophysiology” Section in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant Special Issues is provided below:

“Pathology of Urogenital Cancers”
Guest Editors: Prof. Roberta Mazzucchelli and Dr. Giovanni Tossetta
Cited by 140+
Viewed by 36000+

“Metastatic Progression of Human Melanoma”
Guest Editors: Prof. Dr. Jozsef Tímar and Dr. Andrea Ladányi
Cited by 120+
Viewed by 55000+

“The Role of Tunneling Nanotubes in Intercellular Communication and Pathophysiology of Cancer”
Guest Editor: Dr. Emil Lou
Cited by 110+
Viewed by 31000+

“New Insights in Molecular Pathology of Cancers: From Biomarkers to Therapeutic Targets”
Guest Editor: Dr. Hisham Bahmad
Cited by 60+
Viewed by 22000+

“Advances in Breast Cancer: From Pathogenesis to Therapy”
Guest Editors: Prof. Dr. Ana Isabel Torres-Suárez and Dr. Ana Isabel Fraguas-Sánchez
Cited by 35+
Viewed by 16000+

“Lipids and Small Metabolites in Cancer”
Guest Editors: Dr. Zsolt Balogi and Dr. Laszlo Vigh
Cited by 30+
Viewed by 20000+

We are delighted to share some highly cited Special Issues in 2024 from the “Methods and Technologies Development” Section of Cancers (ISSN: 2072-6694).

The list of highly cited Special Issues can be viewed below:

“Recent Trends in PET/CT Tracer Development and Multimodal Imaging” Guest Editors: Prof. Dr. Olaf Prante and Prof. Dr. Tobias Bäuerle Submission deadline: 30 June 2024	“Radionuclide Therapy and Hybrid Imaging in   Oncology” Guest Editors: Dr. Amir Sabet and Prof. Dr. Frank Grünwald Submission deadline: 29 February 2024
“New Precision Medicine Approaches in Haematological Malignancies: Novel Targets and Advanced Therapies” Guest Editors: Dr. Ilaria Stefania Pagani, Dr. Hannah Wardill and Dr. Teresa Sadras Submission deadline: 31 January 2024	“The Role of PET Imaging in Oncology: New Advancements in Clinical and Research Setting” Guest Editors: Dr. Pierpaolo Alongi and Dr. Desiree Deandreis Submission deadline: 31 March 2024
“Updates on Imaging of Common Urogenital Neoplasms” Guest Editor: Dr. Athina C Tsili Submission deadline: 29 February 2024	“Recent Advances and Challenges in Breast Cancer Surgery” Guest Editor: Dr. Antonio Piñero-Madrona Submission deadline: 30 April 2024

We invite you to read and submit relevant papers to the journal Cancers using the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We cordially invite you to attend the 1st International Online Conference on Hematology organized by the MDPI journals Hematology Reports (ISSN: 2038-8330, Impact Factor 1.2), Hemato (ISSN: 2673-6357, Impact Factor 1.0), and Thalassemia Reports (ISSN: 2039-4365, Impact Factor 1.2). It will take place online from 28 to 30 October 2026, and it is free of charge for all participants.

Conference Chair:

• Prof. Dr. Claudio Cerchione, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.

The topics of interest:

S1. Multiple Myeloma;
S2. Acute Myeloid Leukemia;
S3. Acute Lymphoblastic Leukemia;
S4. Non-Hodgkin Lymphoma;
S5. Hodgkin Lymphoma;
S6. CML and Myeloproliferative Neoplasms;
S7. Stem Cell Transplantation and New Cellular Therapies;
S8. Rare diseases.

Important dates:
Deadline for abstract submission: 29 June 2026;
Notification of acceptance: 28 July 2026;
Deadline for registration: 22 November 2026.

Guide for authors:
To submit your abstract, please click on the following link: https://sciforum.net/user/submission/create/1493.

To register for the event, please click on the following link: https://sciforum.net/event/IOCHE2026?subscribe&section=#registration.

Note: We only accept abstracts for this conference. To publish a conference proceedings paper for free and submit a full manuscript to the organizing journals Hematology Reports (ISSN: 2038-8330, Impact Factor 1.2), Hemato (ISSN: 2673-6357, Impact Factor 1.0) and Thalassemia Reports (ISSN: 2039-4365, Impact Factor 1.2), please refer to the Publication Opportunities section.

Best Presentation Award and Best Poster Award:

• Six winners;
• Each winner will receive a certificate;
• CHF 200 each.

For any enquiries regarding this event, please contact ioche2026@mdpi.com.

We look forward to seeing you at the 1st International Online Conference on Hematology!